Former JD.com Executive Takes Helm at Qilekang to Challenge BAT in Mobile Healthcare with 'Dayunyunzhen' App

Just after the conclusion of the Internet Conference, Qilekang officially announced the appointment ofJiang Haidong, former Vice President of JD.com, former Vice President of Vipshop, and former CTO of Oriental Fengxing Group (the parent company of Lefeng.com), serves as CEO.Meanwhile, Qilekang has made a high-profile announcement that it will officially enter the mobile healthcare arena with its mobile application, “Dayun Clinic.”

Da Baiyun Clinic Interface

Guangzhou Qilekang Pharmaceutical Chain Co., Ltd. was founded in Guangzhou in 2010 by its founder, Shi Zhenyang. It is one of the first enterprises in China to be granted special authorization for online pharmaceutical sales. It was also the first to obtain the initial domestic approval for the pilot establishment of a B2C pharmaceutical logistics network and to build its own nationwide logistics infrastructure. In 2011, it pioneered the online pharmacy business in China. Focusing on the big health industry, the company is an internet enterprise dedicated to building a comprehensive health and wellness management platform.

Before taking the helm at Qilekang, Jiang Haidong was a prominent figure in the e-commerce industry. After Amazon acquired Joyo.com, he led the global team in completing the system migration. In 2009, he joined JD.com as its fourth Vice President, where he conceived and executed the “211” logistics initiative. In 2012, he joined Oriental Wind Group (the parent company of Lepeng.com) as a core partner and served as the Group’s Chief Technology Officer, overseeing corporate operations and technology. In 2014, he joined Vipshop as Vice President, where he rebuilt the company’s supply chain system.

It is understood that Shi Zhenyang will no longer serve as the CEO of Qilekang, with Jiang Haidong taking the helm to oversee all of the company’s operations, including both online and offline businesses. Shi Zhenyang will instead focus on corporate strategic development, corporate culture building, establishment of core corporate values, talent development, core leadership development, and capital management.

At the same time as announcing the appointment of Jiang Haidong, 7lecare officially announced its entry into the mobile healthcare sector, bringing its “Internet + Healthcare ‘Big Health Management Platform’” mobile application—“Da Baiyun Clinic”—into the spotlight. It is reported that“Dayun Baiyun Clinic” was launched and underwent small-scale testing as early as August. Qilekang positions it as a “public benefit initiative,” leveraging mobile internet technology to provide patients with health consultation and management services through multiple channels, including text-and-image and voice communications, thereby meeting their needs for medical consultations, chronic disease management, and self-health management.Qilekang hopes that Dayun Online Clinic will play a positive role in improving doctor-patient relationships, strengthening mutual trust between doctors and patients, and assisting the government in optimizing the healthcare ecosystem.

As a traditional industry, healthcare faces talent challenges in its “Internet Plus” transformation, much like many other traditional sectors. However, with the addition of Jiang Haidong, “Da Bai Yun Zhen” is quietly undergoing a significant transformation. The most notable change is the rapid infusion of professionals adept in internet-based thinking. It is reported that Qilekang’s current core team, in addition to its original key personnel, includes senior executives from well-known internet companies such as JD.com, Vipshop, LeEco, Alibaba, Vancl, and Amazon.

From Jiang Haidong’s perspective, the healthcare industry has long been plagued by issues such as irrational resource allocation and the difficulty and high cost of accessing medical care. These challenges can be addressed through the internet; mobile health can eliminate many intermediary profit-distribution links in the pharmaceutical and healthcare sectors, thereby facilitating reform of the healthcare system. However, Jiang Haidong also pointed out that reforming mobile health is not a matter of transforming a single link; it requires connecting all components through a new order. Yet, no company has so far been able to fully accomplish this transformation.

Compared with other peers, Jiang Haidong believes that Qilekang, which has been engaged in pharmaceutical e-commerce since 2010, possesses greater resource advantages.

It is understood that 7Lekang is one of the first enterprises in China to be specially licensed for online drug sales, pioneering the online pharmacy business domestically in 2011. As the leading brand in pharmaceutical e-commerce, its online sales had exceeded RMB 1 billion by December 2015.

Furthermore, to optimize and integrate pharmaceutical supply chain resources, shorten the delivery time from product to customer, and enhance the user shopping experience, Qilekang officially announced its entry into the pharmaceutical logistics sector with a self-built nationwide logistics network after obtaining China’s first approval for the pilot establishment of B2C pharmaceutical logistics in late 2014.

Qilekang Logistics Team

Currently, the mobile healthcare market is expanding rapidly. Jiang Haidong stated, “The mobile healthcare industry will enter a year of consolidation in 2016, with some platforms or applications disappearing.” The most critical aspect of the mobile healthcare industry is its business logic, and currently, all players are still in an exploratory phase. At present, various capital investors are entering the large mobile healthcare market from different angles, each with their own unique entry points.

Qilekang Enters the Mobile Healthcare Industry with a Multi-Pronged Strategy.Mobile healthcare can be applied in a wide range of scenarios. In each scenario, various components are interconnected via the mobile internet, enabling real-time data flow among patients, physicians, pharmaceutical companies, hospitals, medical device manufacturers, insurance companies, and other stakeholders. The future of mobile healthcare will be revolutionary.“Jiang Haidong pointed out that Qilekang was originally engaged in pharmaceutical e-commerce, possessing mature advantages in industrial chain resources. The Da Baiyun Zhen model will integrate various stages, such as medical consultations, with Qilekang’s existing industrial chain resources, thereby connecting numerous scenarios within the healthcare industry.”

It is understood that, currently, the medical resources gathered by Dayun Clinic have exceeded 60,000 doctors. With the completion of its initial pilot phase, Da Bai Yun Zhen will also open its platform to general users in January next year, with explosive growth anticipated in the coming year. “Through joint efforts with our strategic partners, we expect the number of physicians joining the platform to increase several-fold next year,” pointed out Jiang Haidong. He noted that in the future, Da Bai Yun Zhen will not only connect doctors and patients but also integrate insurance companies and health-sector enterprises—such as medical device manufacturers and other mobile applications—into its ecosystem.

In this process, Jiang Haidong believes that balancing the interests of all stakeholders and optimizing user experience are paramount. At JD.com, the “211” initiative, spearheaded by Jiang, helped establish a logistical advantage that competitors struggled to match: orders placed before 11:00 AM would be delivered on the same day, while those placed before 11:00 PM would arrive the next day. After joining Lefeng, Jiang doubled the company’s business volume and achieved a qualitative leap in system infrastructure. The previous issue of system crashes during promotional events was resolved, enabling the platform to handle tens of millions of daily unique visitors (UV) with ease.

Now leading “Da Bai Yun Zhen,” Jiang Haidong stated that he would leverage his experience to help Da Bai Yun Zhen build a strong core competitive advantage in user experience.

It is reported that,Qilekang Secured RMB 300 Million in Series A Financing in Early 2015. The market value, as appraised by a professional and authoritative third-party firm, has exceeded RMB 3 billion.